CONSTANT LEVERAGE SHORT - MODERNA Share Price

Certificat

4GCNB

FRBNPP06ABB4

Market Closed - Euronext Paris 10:00:02 16/05/2024 pm IST
0.242 EUR -20.13% Intraday chart for CONSTANT LEVERAGE SHORT - MODERNA
Current month-76.68%
1 month-84.17%
Date Price Change
16/24/16 0.242 -20.13%
15/24/15 0.303 +7.83%
14/24/14 0.281 -25.46%
13/24/13 0.377 -22.75%
10/24/10 0.488 +25.45%

Real-time Euronext Paris

Last update May 16, 2024 at 10:00 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying MODERNA, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
4GCNB
ISINFRBNPP06ABB4
Date issued 03/01/2024
Maturity Unlimited
Parity 1 : 1
Emission price 4.535
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 14.38
Lowest since issue 0.242
Spread 0.01
Spread %4.03%

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
129.1 USD
Average target price
138.5 USD
Spread / Average Target
+7.32%
Consensus
  1. Stock Market
  2. Certificates
  3. 4GCNB Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW